Just raised · Biotech & life sciences

SRTD Biotech: funding and hiring

SRTD Biotech develops selectively expressed RNA (seRNA) therapies that activate only in diseased cells, for oncology, autoimmune and fibrosis…

  • €31.5M Seed
  • Announced Nov 9, 2026
  • Recruiter fit 38

Open roles

No public job board found yet. We check again every week, and this page updates when roles go up.

Who to contact

Reach the founder or whoever runs hiring while the headcount plan is still being written. Hiring Radar shows any company's open roles and hiring contacts in your browser.

Funding

SRTD Biotech raised €31.5M Seed, announced November 9, 2026.

Investors: Mérieux Equity Partners

Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells

Company

First seen
Nov 9, 2026

Recruiter fit 38/100

  • Recency +22
  • Round size +16
  • Capped at 40 until we can count their open roles

How the score works · Report a correction

Follow SRTD Biotech

Get an email when SRTD Biotech raises again or posts three or more new roles. Only when something changes.

Other biotech startups hiring after a raise

  1. Orakl Oncology $34M Series A · 10 open roles
  2. Resilience €48M · 3 open roles
  3. Hexagon Bio $62M Series C · 1 open role
  4. Multiply Labs $75M Series B · 14 open roles
  5. Teal Health $22M Series A · 3 open roles

Work at SRTD Biotech?

Add this badge to your careers page or press kit. It links back to this page.

Featured on Work Insiders: Just raised

All startups that just raised